logo
Tempus AI Raises Outlook, CEO Cites Faster-Than-Expected Growth And Improved Margins

Tempus AI Raises Outlook, CEO Cites Faster-Than-Expected Growth And Improved Margins

Yahoo7 hours ago
Tempus AI Inc. (NASDAQ:TEM) reported second-quarter financial results Friday.
The AI-focused precision medicine and patient care company reported a second-quarter adjusted loss of 22 cents per share, beating analyst estimates for a loss of 24 cents per share.
Tempus AI reported quarterly revenue of $314.64 million, beating the consensus estimates of $296.85 million. Revenue increased 89.6% year-over-year.
Genomics contributed $241.8 million in revenue in the quarter, growing 115.3% year over year.Oncology testing (Tempus genomics) delivered $133.2 million of revenue, up 32.9%, with approximately 26% volume growth versus 20% last quarter.
Hereditary testing sales (Ambry genetics) reached $97.3 million, up 33.6% year-over-year on a pro forma basis with approximately 32% volume growth.
Revenue from Data and services totaled $72.8 million, delivering 35.7% growth versus the second quarter of 2024, led by Insights (data licensing), which grew 40.7% year-over-year.
Adjusted EBITDA of ($5.6 million) in the second quarter of 2025 compared to ($31.2 million) in the second quarter of 2024, an improvement of $25.6 million year-over-year.
View more earnings on TEM
'The business is performing well with revenues and margins growing faster than expected, contributing to our continued improvement in adjusted EBITDA on a year-over-year basis,' said Eric Lefkofsky, Founder and CEO of Tempus.
'We saw significant re-acceleration of our clinical volumes, which grew 30% in the quarter, as we delivered more than 212,000 NGS tests,' Lefkofsky said in a statement on Friday.
Database Update
Through more than 4,500 integrations, Tempus said it connected to more than 40 million clinical patient records, with around 9 million de-identified and ingested, spanning approximately 1.1 billion healthcare documents, a significant percentage of which are connected to the around 4 million samples the company has sequenced.
As a result, the company's database stands at over 350 petabytes of connected clinical and molecular data.
Tempus AI ended the quarter with $293.0 million in cash and marketable securities, an improvement of around $70 million over last quarter.
Outlook
Tempus AI increased its guidance and expects a full year of 2025 revenue of approximately $1.26 billion for the consolidated business, representing approximately 82% annual growth, compared to the consensus of $1.25 billion.
Earlier, the company expected revenue between $1.24 billion and $1.25 billion for its consolidated Tempus and Ambry Genetics business.
The company reaffirms full-year 2025 adjusted EBITDA of $5 million, an improvement of approximately $110 million over 2024.
Tempus AI received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ejection fraction software in July.
Tempus said the FDA granted it 510(k) clearance for its Tempus ECG-Low EF software, which uses AI to identify patients with a potential left ventricular ejection fraction.
Price Action: Tempus AI shares were up 5.79% after hours, trading at $55.21 at the time of publication on Tuesday.
Read Next:Photo by Piotr Swat via Shutterstock
Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market.
Get the latest stock analysis from Benzinga?
This article Tempus AI Raises Outlook, CEO Cites Faster-Than-Expected Growth And Improved Margins originally appeared on Benzinga.com
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Today's Market: S&P 500, Nasdaq Climb as Trump Tariffs Take Hold
Today's Market: S&P 500, Nasdaq Climb as Trump Tariffs Take Hold

Yahoo

time2 minutes ago

  • Yahoo

Today's Market: S&P 500, Nasdaq Climb as Trump Tariffs Take Hold

Aug 8 - U.S. stock index futures rose Friday morning, with S&P 500 climbing about 0.7%, Nasdaq 100 up more than 0.8% and Dow edging up about 0.5%, as investors weighed a fresh tariffs deadline and a potential dovish shift at the Federal Reserve. Tech shares led gains after indications that some semiconductor imports could qualify for domestic manufacturing exemptions, sending the Nasdaq Composite toward a fresh record peak. Warning! GuruFocus has detected 6 Warning Signs with OXSQ. Meanwhile, President Donald Trump's nomination of economist Stephen Miran to temporarily replace outgoing Fed Governor Adriana Kugler bolstered market bets on interest-rate cuts as soon as next monthReuters. With reciprocal tariffs kicking in at midnight Thursday, traders face a weekend assessing the policies' implications for corporate costs and global supply chains. Additionally, investors are monitoring a planned U.S.-Russia summit next week, where Trump will meet President Vladimir Putin amid ongoing Ukraine tensions, and Ukrainian President Volodymyr Zelenskiy's calls for deeper European engagement in peace efforts. Moreover, attention is turning to next Tuesday's July Consumer Price Index report, a key gauge that could delay or accelerate the Fed's rate-cut timetableReuters. Volume remained light. This article first appeared on GuruFocus.

Why Are Essent Group (ESNT) Shares Soaring Today
Why Are Essent Group (ESNT) Shares Soaring Today

Yahoo

time2 minutes ago

  • Yahoo

Why Are Essent Group (ESNT) Shares Soaring Today

What Happened? Shares of mortgage insurance provider Essent Group (NYSE:ESNT) jumped 6.2% in the afternoon session after the company reported decent second-quarter results that saw earnings beat expectations while a key revenue component fell short. The mortgage insurance provider posted earnings per share of $1.93, comfortably surpassing analyst estimates of $1.71. Total revenue also edged past forecasts, coming in at $319.1 million against an expected $316.8 million. However, this positive news was tempered by a 1.2% year-over-year decline in net premiums earned, a core metric for insurers, which also missed Wall Street's consensus. Is now the time to buy Essent Group? Access our full analysis report here, it's free. What Is The Market Telling Us Essent Group's shares are not very volatile and have only had 2 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business. Essent Group is up 11.4% since the beginning of the year, and at $60.68 per share, it is trading close to its 52-week high of $64.90 from October 2024. Investors who bought $1,000 worth of Essent Group's shares 5 years ago would now be looking at an investment worth $1,617. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Student loan delinquencies are on the rise. Here's why.
Student loan delinquencies are on the rise. Here's why.

Yahoo

time2 minutes ago

  • Yahoo

Student loan delinquencies are on the rise. Here's why.

Student loan delinquencies are surging after a years-long relief period ended for borrowers behind on their payments. Of the country's aggregate student debt, 10.2% was reported as more than 90 days delinquent in the second quarter of 2025, according to the Federal Reserve Bank of New York. Meanwhile, 12.9% of student loans entered serious delinquency in that time period, the highest rate in 21 years of data. Read more: After Trump's budget bill, are federal student loans still the gold standard? 'Missed federal student loan payments that were not previously reported to credit bureaus between Q2 2020 and Q4 2024 are now appearing in credit reports,' the New York Fed said in a press release. 'Consequently, student loan delinquency rates continued to rise.' Sign up for the Mind Your Money weekly newsletter By subscribing, you are agreeing to Yahoo's Terms and Privacy Policy The repayment issue has come full circle from March 2020, when Congress passed a massive COVID-19 relief package that allowed borrowers to pause payments on federal student loans without penalty, reduced interest rates to 0%, and stopped reporting missed payments to credit bureaus. Delinquency rates fell to less than 1%. After that provision was extended several times, interest rates resumed in September 2023, and payments restarted in October of that year. Still, there was an 'on-ramp' period for a year, said Preston Cooper, a senior fellow at the American Enterprise Institute, a conservative think tank. Even though payments were technically due, missed payments didn't damage borrowers' credit scores, and delinquencies weren't recorded. That policy expired last fall, and delinquencies began appearing on credit reports again this year. 'This is when the trouble kind of began,' Cooper told Yahoo Finance. 'We have a lot of people who had been told over and over again that payments are going to be due, only for the pause to be extended. Now they're told payments are going to be due, and the pause actually does end. You can imagine a lot of people just really weren't paying attention.' During the relief period, many borrowers also moved, changed their loan servicers, and changed their contact information, Cooper said. 'We're not in a great situation right now,' Cooper said. 'The percentage of borrowers who are in current repayment on their loans is just about 35%, according to the most recent data, which was in March. We have delinquencies being very elevated, we have a lot of people in forbearance, and we have repayment rates that are very far below what they were pre-pandemic.' Learn more: 10 ways the One Big Beautiful Bill affects student loans and financial aid Joshua Turnbull, senior vice president and head of consumer lending at TransUnion, recently wrote that delinquencies have particularly increased among prime and super-prime borrowers who may have the capacity to pay but may be facing 'confusion, budgeting inexperience, or a belief that further relief may be coming.' These delinquent borrowers aren't fresh grads, either. The New York Fed noted in May that the average age of a delinquent borrower was just over 40. 'We're going into a new era in terms of how many people are going to be going into default,' Cooper said. Read more: Tips and tricks for paying off student loans quickly Emma Ockerman is a reporter covering the economy and labor for Yahoo Finance. You can reach her at Sign up for the Mind Your Money newsletter Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store